Far-Infrared Therapy
Open Access
- 1 March 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 18 (3), 985-992
- https://doi.org/10.1681/asn.2006050534
Abstract
Vascular access malfunction, usually presenting with an inadequate access flow (Qa), is the leading cause of morbidity and hospitalization in hemodialysis (HD) patients. Many methods of thermal therapy have been tried for improving Qa but with limited effects. This randomized trial was designed to evaluate the effect of far-infrared (FIR) therapy on access flow and patency of the native arteriovenous fistula (AVF). A total of 145 HD patients were enrolled with 73 in the control group and 72 in the FIR group. A WS TY101 FIR emitter was used for 40 min, and hemodynamic parameters were measured by the Transonic HD02 monitor during HD. The Qa1/Qa2 and Qa3/Qa4 were defined as the Qa measured at the beginning/at 40 min later in the HD session before the initiation and at the end of the study, respectively. The incremental change of Qa in the single HD session with FIR therapy was significantly higher than that without FIR therapy (13.2 ± 114.7 versus −33.4 ± 132.3 ml/min; P = 0.021). In comparison with control subjects, patients who received FIR therapy for 1 yr had (1) a lower incidence (12.5 versus 30.1%; P < 0.01) and relative incidence (one episode per 67.7 versus one episode per 26.7 patient-months; P = 0.03) of AVF malfunction; (2) higher values of the following parameters, including Δ(Qa4 − Qa3) (36.2 ± 82.4 versus −12.7 ± 153.6 ml/min; P = 0.027), Δ(Qa3 − Qa1) (36.3 ± 166.2 versus −51.7 ± 283.1 ml/min; P = 0.035), Δ(Qa4 − Qa2) (99.2 ± 144.4 versus −47.5 ± 244.5 ml/min; P < 0.001), and Δ(Qa4 − Qa2) − Δ(Qa3 − Qa1) (62.9 ± 111.6 versus 4.1 ± 184.5 ml/min; P = 0.032); and (3) a better unassisted patency of AVF (85.9 versus 67.6%; P < 0.01). In conclusion, FIR therapy, a noninvasive and convenient therapeutic modality, can improve Qa and survival of the AVF in HD patients through both its thermal and its nonthermal effects.Keywords
This publication has 19 references indexed in Scilit:
- Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgeryBritish Journal of Surgery, 2006
- Hemodialysis Vascular Access DysfunctionJournal of the American Society of Nephrology, 2006
- Biological effect of far‐infrared therapy on increasing skin microcirculation in ratsPhotodermatology, Photoimmunology & Photomedicine, 2006
- Pregnancy Effects on Rat Adipose Tissue Lipolytic Capacity are Dependent on Anatomical LocationCellular Physiology and Biochemistry, 2005
- Repeated Sauna Therapy Reduces Urinary 8-Epi-Prostaglandin F2.ALPHA.Japanese Heart Journal, 2004
- III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000American Journal of Kidney Diseases, 2001
- New ultrasound approaches to dialysis access monitoringAmerican Journal of Kidney Diseases, 2000
- Theory and validation of access flow measurement by dilution technique during hemodialysisKidney International, 1995
- Permanent Vascular Access: A Nephrologist's ViewAmerican Journal of Kidney Diseases, 1993
- Sleep-enhancing effects of far-infrared radiation in ratsInternational Journal of Biometeorology, 1988